VetSRev
Database of veterinary systematic reviews
Database of veterinary systematic reviews
BMC Complement Altern Med (2019) 19: 290
DOI: 10.1186/s12906-019-2706-2
BACKGROUND: Nigella sativa or commonly known as black seed or black cumin is one of the most ubiquitous complementary medicine. Epithelial to mesenchymal transition (EMT) of type 2 is defined by the balance between wound healing and tissue fibrosis, which is dependent to the state of inflammation. This systematic review is conducted to provide an overview regarding the reported effect of Nigella sativa and its bioactive compound on the type 2 EMT. METHODS: A search was done in EBSCOHOST, OVID and SCOPUS database to obtain potentially relevant articles that were published between 1823 and August 2019. This review includes studies that focus on the effect of Nigella sativa and its bioactive compound on the events related to type 2 EMT. RESULTS: A total of 1393 research articles were found to be potentially related to the effect of Nigella sativa and its bioactive compound, thymoquinone on Type 2 EMT. After screening was done, 22 research articles met inclusion criteria and were included in this review. Majority of the studies, reported better wound healing rate or significant prevention of tissue inflammation and organ fibrosis following Nigella sativa or thymoquinone treatments. In terms of wound healing, studies included reported progression of EMT related pathological changes after treatment with Nigella sativa or thymoquinone. Alternatively, in terms of fibrosis and inflammation, studies included reported reversal of pathological changes related to EMT after treatment with Nigella sativa or thymoquinone. CONCLUSION: Through this review, Nigella sativa and thymoquinone have been associated with events in Type 2 EMT. They have been shown to promote wound healing, attenuate tissue inflammation, and prevent organ fibrosis via regulation of the EMT process.
Nordin, A., Kamal, H., Yazid, M. D., Saim, A., & Idrus, R. (2019). Effect of Nigella sativa and its bioactive compound on type 2 epithelial to mesenchymal transition: a systematic review. BMC Complement Altern Med, 19(1), 290. https://doi.org/10.1186/s12906-019-2706-2 Animals, Humans, Fibrosis, Epithelial-Mesenchymal Transition/*drug effects, Treatment Outcome, Wound healing, Phytotherapy, Mesenchymal, Benzoquinones/analysis/therapeutic use, Epithelial, Nigella sativa, Nigella sativa/*chemistry, Plant Extracts/*chemistry/*therapeutic use, Thymoquinone, Wounds and Injuries/*drug therapy/physiopathology